PR Newswire – Page 253

Brand Post October 23, 2025

Joget Unlocks Autonomous Productivity Across HR, Procurement, Customer Service, and Supply Chain with No-Code AI Agent Builder

Joget AI Agent Builder enables teams across every department to create goal-driven agents that execute autonomously, yet remain governed by…

Brand Post October 23, 2025

Tellius Launches Agent Mode: The Next Evolution of the AI Analyst

Kaiya now plans, reasons, and executes multi-step analytic workflows autonomously—leveraging SQL, Python, and contextual intelligence to deliver 20× deeper insights…

Brand Post September 8, 2025

Sirnaomics Announces Strategic Equity Investment by Bloomage Biotech to Jointly Advance Next-Generation Life Science Pipelines

HONG KONG, Sept. 7, 2025 /PRNewswire/ — Sirnaomics Ltd. (the “Company“, together with its subsidiaries, the “Group” or “Sirnaomics“; Stock…

Brand Post September 8, 2025

Commitment to Investor

Excellence Kelyniam Global, Inc. Uplists to OTCID Market Tier CANTON, Conn., Sept. 8, 2025 /PRNewswire/ — Kelyniam Global, Inc. (OTC:…

Brand Post September 8, 2025

Eisai Presents Clinical Study Results of Novel Orexin Receptor Agonist E2086 for Narcolepsy at World Sleep 2025

E2086 Showed Potential to Improve Wakefulness in People Living with Narcolepsy Type 1 TOKYO, Sept. 8, 2025 /PRNewswire/ — Eisai…

Brand Post September 7, 2025

LIGHT OF THE WORLD CELEBRATES OPENING WEEKEND WITH AN “A” CINEMA SCORE

Audiences Embrace the Story of Jesus in Stunning 2D Animation SPARTA, Wis., Sept. 7, 2025 /PRNewswire/ — LIGHT OF THE…

Brand Post September 7, 2025

New Data Reveals Path to SEP-1 Success Includes Early Sepsis Risk Stratification

Study reveals how Cytovale’s IntelliSep® sepsis test enables early sepsis risk stratification and more precise documentation, increasing SEP-1 compliance by…

Brand Post September 7, 2025

“Stand Up Sunday” National Interfaith Coalition Calls for an End to Antisemitism and All Faith-based Hate

Appeal of Conscience Foundation and the Foundation to Combat Antisemitism Bring Together Interfaith Coalition of Religious Leaders and Houses of…

Brand Post September 7, 2025

IDEAYA Biosciences and Hengrui Pharma Present Positive Phase 1 Data for IDE849 (SHR-4849), a Potential First-in-Class DLL3 TOP1 ADC, in Small Cell Lung Cancer at the IASLC 2025 World Conference on Lung Cancer

80.0% (8/10) ORR and 70.0% (7/10) confirmed ORR in 2L SCLC; a 73.7% (14/19) ORR and 57.9% (11/19) confirmed ORR…

Brand Post September 7, 2025

BLUETTI at IFA Berlin 2025: Empowering a Greener Tomorrow with Clean Energy

BERLIN, Sept. 7, 2025 /PRNewswire/ — At IFA Berlin, BLUETTI, a leading provider of energy storage solutions, unveils three breakthroughs: the…